I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
P‑Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and ..:
Margarida L. F. Martins (11642297)
;
Nancy H. C. Loos (11642300)
;
Sümeyra Mucuk (11642303)
...
https://figshare.com/articles/journal_contribution/P_Glycoprotein_ABCB1_MDR1_Controls_Brain_Penetration_and_Intestinal_Disposition_of_the_PARP1_2_Inhibitor_Niraparib/16924214. , 2021
Link:
https://doi.org/10.1021/acs.molpharmaceut.1c00553.s001
RT Journal T1
P‑Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16924214&Exemplar=1&LAN=DE A1 Margarida L. F. Martins (11642297) A1 Nancy H. C. Loos (11642300) A1 Sümeyra Mucuk (11642303) A1 Danielle de Jong (3636856) A1 Maria C. Lebre (11642306) A1 Hilde Rosing (1519048) A1 Matthijs Tibben (7135145) A1 Jos H. Beijnen (321342) A1 Alfred H. Schinkel (1469320) YR 2021 K1 Biophysics K1 Biochemistry K1 Medicine K1 Cell Biology K1 Genetics K1 Molecular Biology K1 Neuroscience K1 Physiology K1 Pharmacology K1 Developmental Biology K1 Mental Health K1 Infectious Diseases K1 Computational Biology K1 Chemical Sciences not elsewhere classified K1 sup >–/–</ sup K1 p ‑ glycoprotein K1 later time points K1 findings may support K1 cell line models K1 including brain tumors K1 controls brain penetration K1 small intestinal content K1 reduced biliary excretion K1 genetically modified mouse K1 > K1 human abcb1 K1 1b uptake transporters K1 oral niraparib pharmacokinetics K1 niraparib plasma exposure K1 selective oral parp1 K1 elacridar pretreatment inhibited K1 2 inhibitor registered K1 oral elacridar K1 niraparib brain K1 plasma ratios K1 intestinal disposition K1 abcg2 inhibitor K1 niraparib recovery K1 ∼ 2 K1 zejula ) K1 significant effects K1 processes completely K1 negligible role K1 metabolizing complex K1 markedly reduced K1 liver distribution K1 fold increased K1 fallopian tube K1 deficient strains K1 cyp3a drug JF https://figshare.com/articles/journal_contribution/P_Glycoprotein_ABCB1_MDR1_Controls_Brain_Penetration_and_Intestinal_Disposition_of_the_PARP1_2_Inhibitor_Niraparib/16924214 LK http://dx.doi.org/https://doi.org/10.1021/acs.molpharmaceut.1c00553.s001 DO https://doi.org/10.1021/acs.molpharmaceut.1c00553.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)